Healthpeak Properties, Inc. $DOC Stock Holdings Lifted by Aberdeen Group plc

Aberdeen Group plc increased its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 4.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 1,356,606 shares of the real estate investment trust’s stock after buying an additional 54,914 shares during the period. Aberdeen Group plc owned about 0.20% of Healthpeak Properties worth $21,814,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of DOC. Mather Group LLC. bought a new position in shares of Healthpeak Properties during the third quarter valued at approximately $25,000. City Holding Co. bought a new stake in shares of Healthpeak Properties in the 3rd quarter worth approximately $26,000. Rexford Capital Inc. bought a new stake in shares of Healthpeak Properties in the 2nd quarter worth approximately $28,000. Sound Income Strategies LLC acquired a new position in Healthpeak Properties during the 3rd quarter valued at approximately $28,000. Finally, CYBER HORNET ETFs LLC acquired a new position in Healthpeak Properties during the 2nd quarter valued at approximately $33,000. Institutional investors own 93.57% of the company’s stock.

Analysts Set New Price Targets

DOC has been the topic of several analyst reports. Argus lowered Healthpeak Properties from a “buy” rating to a “hold” rating in a research report on Thursday, February 5th. Weiss Ratings raised shares of Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 26th. Cantor Fitzgerald set a $17.00 price target on shares of Healthpeak Properties in a research report on Monday, January 5th. Evercore dropped their price objective on shares of Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating on the stock in a report on Wednesday, February 4th. Finally, Wall Street Zen downgraded shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Saturday, March 28th. Six analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $19.27.

Healthpeak Properties Price Performance

Shares of NYSE DOC opened at $16.53 on Monday. Healthpeak Properties, Inc. has a twelve month low of $15.71 and a twelve month high of $20.10. The company has a current ratio of 2.82, a quick ratio of 2.82 and a debt-to-equity ratio of 1.21. The firm has a 50-day moving average of $17.07 and a two-hundred day moving average of $17.44. The company has a market capitalization of $11.49 billion, a price-to-earnings ratio of 165.27, a PEG ratio of 8.84 and a beta of 1.10.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.02. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The company had revenue of $719.40 million for the quarter, compared to analysts’ expectations of $685.14 million. During the same quarter in the previous year, the company posted $0.46 EPS. The business’s revenue was up 3.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, analysts expect that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.